Published in Cell Death Differ on November 05, 2010
Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov (2012) 3.88
Necroptosis. N Engl J Med (2014) 2.71
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ (2014) 2.66
Many stimuli pull the necrotic trigger, an overview. Cell Death Differ (2011) 2.55
Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol (2011) 2.40
Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol (2012) 2.25
Retracted GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J Cell Sci (2012) 2.05
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis (2012) 1.94
Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood (2013) 1.74
Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell Rep (2013) 1.59
TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis (2011) 1.53
RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. Nature (2014) 1.53
CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis. PLoS One (2013) 1.48
TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Cell Death Dis (2013) 1.46
Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc Natl Acad Sci U S A (2012) 1.37
RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ (2013) 1.36
Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death Dis (2014) 1.33
RIP1-dependent and independent effects of necrostatin-1 in necrosis and T cell activation. PLoS One (2011) 1.33
cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ (2012) 1.29
Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ (2014) 1.29
Programmed necrosis in the cross talk of cell death and inflammation. Annu Rev Immunol (2014) 1.27
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ (2014) 1.14
Brain endothelial TAK1 and NEMO safeguard the neurovascular unit. J Exp Med (2015) 1.10
TAK1 control of cell death. Cell Death Differ (2014) 1.09
Necroptosis: is there a role for mitochondria? Front Physiol (2014) 1.08
Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis. Neoplasia (2011) 1.08
TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation. J Cell Biol (2014) 1.07
Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis. Biochem J (2013) 1.07
NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1. PLoS One (2012) 1.07
Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat Commun (2012) 1.06
A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy. Oncogene (2013) 1.06
cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4). PLoS One (2011) 1.06
Programmed necrosis and autophagy in immune function. Immunol Rev (2012) 1.05
TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol Cell Biol (2012) 1.05
New components of the necroptotic pathway. Protein Cell (2012) 1.04
Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate. Biochim Biophys Acta (2011) 1.04
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities. Leukemia (2014) 1.04
Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis. Cell Death Dis (2013) 1.04
Fueling the flames: Mammalian programmed necrosis in inflammatory diseases. Cold Spring Harb Perspect Biol (2012) 1.03
The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis. Dev Cell (2016) 1.02
Small-molecule SMAC mimetics as new cancer therapeutics. Pharmacol Ther (2014) 0.99
Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death. Oncogene (2015) 0.99
NRF2 and p53: Januses in cancer? Oncotarget (2012) 0.98
TAK1 regulates hepatic cell survival and carcinogenesis. J Gastroenterol (2014) 0.97
The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling. Nat Rev Immunol (2012) 0.97
Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production. Oncotarget (2015) 0.96
SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death. EMBO Rep (2016) 0.95
IAP proteins as targets for drug development in oncology. Onco Targets Ther (2013) 0.95
Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs). Cells (2013) 0.95
The prevalence of TNFα-induced necrosis over apoptosis is determined by TAK1-RIP1 interplay. PLoS One (2011) 0.94
TRAF2 is a biologically important necroptosis suppressor. Cell Death Differ (2015) 0.94
The mechanism of necroptosis in normal and cancer cells. Cancer Biol Ther (2013) 0.93
Cell death signaling and anticancer therapy. Front Oncol (2011) 0.91
Photoreceptor cell death and rescue in retinal detachment and degenerations. Prog Retin Eye Res (2013) 0.91
CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN. Cell Rep (2016) 0.90
Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. J Biol Chem (2012) 0.90
RIP kinase-mediated necrosis as an alternative mechanisms of photoreceptor death. Oncotarget (2011) 0.85
Rip3 knockdown rescues photoreceptor cell death in blind pde6c zebrafish. Cell Death Differ (2014) 0.85
Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination. Cell Death Dis (2015) 0.85
The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress. Cells (2012) 0.84
Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2. Int J Mol Sci (2012) 0.83
Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis. Cell Death Dis (2015) 0.82
Alternative cell death pathways and cell metabolism. Int J Cell Biol (2013) 0.82
Tag7 (PGLYRP1) in Complex with Hsp70 Induces Alternative Cytotoxic Processes in Tumor Cells via TNFR1 Receptor. J Biol Chem (2015) 0.81
Cancer therapy in the necroptosis era. Cell Death Differ (2016) 0.81
The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells. PLoS One (2015) 0.81
Distinct roles for the cellular inhibitors of apoptosis proteins 1 and 2. Cell Death Dis (2011) 0.81
PARP1-mediated necrosis is dependent on parallel JNK and Ca²⁺/calpain pathways. J Cell Sci (2014) 0.80
Post-translational control of RIPK3 and MLKL mediated necroptotic cell death. F1000Res (2015) 0.80
Inhibitor of apoptosis proteins in pediatric leukemia: molecular pathways and novel approaches to therapy. Front Oncol (2014) 0.80
TAK1 regulates Paneth cell integrity partly through blocking necroptosis. Cell Death Dis (2016) 0.79
Neisseria gonorrhoeae Modulates Cell Death in Human Endocervical Epithelial Cells through Export of Exosome-Associated cIAP2. Infect Immun (2015) 0.79
More to Life than NF-κB in TNFR1 Signaling. Trends Immunol (2016) 0.79
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy. Oncotarget (2016) 0.78
Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Mol Cancer (2016) 0.78
Poly-ubiquitination in TNFR1-mediated necroptosis. Cell Mol Life Sci (2016) 0.78
RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun (2017) 0.78
A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis. Cell Death Differ (2016) 0.77
Role of necroptosis in the pathogenesis of solid organ injury. Cell Death Dis (2015) 0.77
IAPs, TNF, inflammation and Jürg Tschopp; a personal perspective. Cell Death Differ (2012) 0.76
TAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints. Cell Death Dis (2016) 0.76
Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis. Trends Pharmacol Sci (2017) 0.75
SPATA2: New insights into the assembly of the TNFR signaling complex. Cell Cycle (2016) 0.75
The role of necroptosis in neurosurgical diseases. Braz J Med Biol Res (2015) 0.75
Galactose protects hepatocytes against TNF-α-induced apoptosis by promoting activation of the NF-κB signaling pathway in acute liver failure. Lab Invest (2015) 0.75
Cardioprotective effect of notoginsenoside R1 in a rabbit lung remote ischemic postconditioning model via activation of the TGF-β1/TAK1 signaling pathway. Exp Ther Med (2016) 0.75
Matrine induces RIP3-dependent necroptosis in cholangiocarcinoma cells. Cell Death Discov (2017) 0.75
Silica nanoparticles induce reversible damage of spermatogenic cells via RIPK1 signal pathways in C57 mice. Int J Nanomedicine (2016) 0.75
Regulation of Siglec-8-induced intracellular reactive oxygen species production and eosinophil cell death by Src family kinases. Immunobiology (2016) 0.75
Hyperosmotic stress enhances cytotoxicity of SMAC mimetics. Cell Death Dis (2017) 0.75
TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature (2001) 11.84
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol (2005) 11.63
Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell (2009) 11.36
Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell (2009) 11.26
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science (2009) 9.29
Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol (2008) 9.24
Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell (2005) 9.16
Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol (2010) 9.06
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol (2000) 8.49
IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell (2007) 8.48
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell (2007) 7.74
The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity (1998) 7.35
TNF-alpha induces two distinct caspase-8 activation pathways. Cell (2008) 6.81
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell (2008) 5.89
TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell (2007) 4.53
Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med (1998) 4.08
The emerging complexity of protein ubiquitination. Biochem Soc Trans (2009) 3.85
Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem (1992) 3.76
c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem (2008) 3.54
Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem (2003) 3.35
Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A (2008) 3.27
RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ (2007) 2.96
RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ (2009) 2.59
The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem (2005) 2.47
Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ (2009) 2.33
Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med (1998) 2.11
Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol (2009) 2.02
Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat Immunol (2009) 1.86
The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep (2003) 1.73
Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro. FEBS Lett (2004) 1.69
Molecular mechanisms and pathophysiology of necrotic cell death. Curr Mol Med (2008) 1.63
Riboflavin kinase couples TNF receptor 1 to NADPH oxidase. Nature (2009) 1.62
Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ (2002) 1.59
The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J Biol Chem (2009) 1.44
Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ (2009) 1.43
Cloning and characterization of the rat homologues of the Inhibitor of Apoptosis protein 1, 2, and 3 genes. BMC Genomics (2002) 1.18
Butylated hydroxyanisole is more than a reactive oxygen species scavenger. Cell Death Differ (2006) 1.15
X chromosome-linked inhibitor of apoptosis regulates cell death induction by proapoptotic receptor agonists. J Biol Chem (2009) 1.08
Necrosis is associated with IL-6 production but apoptosis is not. Cell Signal (2005) 1.05
Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis. Neoplasia (2008) 1.00
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Two CD95 (APO-1/Fas) signaling pathways. EMBO J (1998) 10.42
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med (1993) 4.30
Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med (1998) 4.08
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene (1999) 3.42
Caspases in cell survival, proliferation and differentiation. Cell Death Differ (2006) 3.39
RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ (2007) 2.96
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ (2005) 2.91
Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis (2010) 2.61
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ (2011) 2.60
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest (1999) 2.55
Many stimuli pull the necrotic trigger, an overview. Cell Death Differ (2011) 2.55
The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ (2002) 2.42
Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ (2009) 2.33
B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). EMBO J (1987) 2.30
Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family. Cell Death Differ (2007) 2.12
Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med (1998) 2.11
Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ (2001) 2.03
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis (2012) 1.94
Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol (1994) 1.92
Human TNF mutants with selective activity on the p55 receptor. Nature (1993) 1.91
Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ (2003) 1.91
Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ (2002) 1.88
Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett (1999) 1.83
The mitochondrial serine protease HtrA2/Omi: an overview. Cell Death Differ (2008) 1.77
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ (2012) 1.72
TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J Biol Chem (2000) 1.67
Connexin-related signaling in cell death: to live or let die? Cell Death Differ (2009) 1.67
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. Gut (2010) 1.63
Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation. J Biol Chem (2001) 1.60
Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ (2002) 1.59
Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine (1997) 1.54
P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett (1999) 1.54
TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis (2011) 1.53
The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ (2002) 1.52
Death penalty for keratinocytes: apoptosis versus cornification. Cell Death Differ (2005) 1.52
Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy. Blood (2001) 1.51
Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of bid. J Biol Chem (2001) 1.49
Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci (2001) 1.48
Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett (1997) 1.44
Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ (2013) 1.42
Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene (2006) 1.42
The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem (1998) 1.41
The proteolytic procaspase activation network: an in vitro analysis. Cell Death Differ (1999) 1.41
The Drosophila inhibitor of apoptosis D-IAP1 suppresses cell death induced by the caspase drICE. FEBS Lett (1998) 1.39
Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells. Oncogene (2006) 1.37
Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J (2011) 1.37
Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem (1995) 1.37
RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ (2013) 1.36
Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett (1998) 1.35
Gap junctions and the propagation of cell survival and cell death signals. Apoptosis (2005) 1.35
Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ (2000) 1.32
Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells. Cell Death Differ (2006) 1.30
Cytotoxic drugs and the CD95 pathway. Leukemia (1999) 1.30
Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation (2000) 1.30
Redox regulation of TNF signaling. Biofactors (1999) 1.29
TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflamm (1997) 1.27
Characterization of seven murine caspase family members. FEBS Lett (1997) 1.26
Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol (1990) 1.26
The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Exp Oncol (2012) 1.25
Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci U S A (1999) 1.25
PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis. Oncogene (2010) 1.24
TNF-alpha receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology (2002) 1.22
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ (2001) 1.21
Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia (1997) 1.19
Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Invest Dermatol (2000) 1.19
Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Oncogene (2010) 1.17
Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process. Cell Death Differ (2012) 1.17
Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor. J Biol Chem (1997) 1.17
Pleiotropic effects of sonic hedgehog on muscle satellite cells. Cell Mol Life Sci (2005) 1.15
The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component. J Biol Chem (2001) 1.15
Cathepsin B-mediated activation of the proinflammatory caspase-11. Biochem Biophys Res Commun (1998) 1.15
RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis. Leukemia (2011) 1.15
Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants. EMBO J (1994) 1.15
Butylated hydroxyanisole is more than a reactive oxygen species scavenger. Cell Death Differ (2006) 1.15
Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy (2010) 1.14
The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J Biol Chem (1999) 1.14
Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ (2011) 1.13
RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex. Oncogene (2012) 1.12
Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8. Oncogene (2009) 1.12